Abiraterone
The metabolism of Bexarotene can be decreased when combined with Abiraterone.
Acetyldigitoxin
Acetyldigitoxin may decrease the cardiotoxic activities of Bexarotene.
All-Trans-Retinol
The risk or severity of adverse effects can be increased when Vitamin A is combined with Bexarotene.
Advertisement
Amiodarone
The metabolism of Bexarotene can be decreased when combined with Amiodarone.
Ancestim
The risk or severity of cytotoxicity can be increased when Ancestim is combined with Bexarotene.
Apalutamide
The serum concentration of Bexarotene can be decreased when it is combined with Apalutamide.
Advertisement
Aprepitant
The serum concentration of Bexarotene can be increased when it is combined with Aprepitant.
Aripiprazole
The serum concentration of Aripiprazole can be decreased when it is combined with Bexarotene.
Atazanavir
The metabolism of Bexarotene can be decreased when combined with Atazanavir.
Advertisement
Atomoxetine
The metabolism of Bexarotene can be decreased when combined with Atomoxetine.
Atorvastatin
The serum concentration of Atorvastatin can be decreased when it is combined with Bexarotene.
Bevacizumab
Bevacizumab may increase the cardiotoxic activities of Bexarotene.
Bevacizumab-Awwb
Bevacizumab may increase the cardiotoxic activities of Bexarotene.
Boceprevir
The metabolism of Bexarotene can be decreased when combined with Boceprevir.
Bortezomib
The metabolism of Bexarotene can be decreased when combined with Bortezomib.
Bosentan
The serum concentration of Bexarotene can be decreased when it is combined with Bosentan.
Cabazitaxel
The risk or severity of adverse effects can be increased when Cabazitaxel is combined with Bexarotene.
Capecitabine
The metabolism of Bexarotene can be decreased when combined with Capecitabine.
Carbamazepine
The metabolism of Bexarotene can be increased when combined with Carbamazepine.
Carboplatin
The serum concentration of Bexarotene can be increased when it is combined with Carboplatin.
Ceritinib
The serum concentration of Bexarotene can be increased when it is combined with Ceritinib.
Chlorotrianisene
The serum concentration of Chlorotrianisene can be decreased when it is combined with Bexarotene.
Chlortetracycline
The risk or severity of adverse effects can be increased when Chlortetracycline is combined with Bexarotene.
Cholecalciferol
The metabolism of Bexarotene can be decreased when combined with Cholecalciferol.
Clarithromycin
The metabolism of Bexarotene can be decreased when combined with Clarithromycin.
Clemastine
The metabolism of Bexarotene can be decreased when combined with Clemastine.
Clotrimazole
The metabolism of Bexarotene can be decreased when combined with Clotrimazole.
Clozapine
The risk or severity of adverse effects can be increased when Bexarotene is combined with Clozapine.
Cobicistat
The metabolism of Bexarotene can be decreased when combined with Cobicistat.
Conivaptan
The serum concentration of Conivaptan can be increased when it is combined with Bexarotene.
Crisaborole
The metabolism of Bexarotene can be decreased when combined with Crisaborole.
Crizotinib
The metabolism of Bexarotene can be decreased when combined with Crizotinib.
Cyclophosphamide
Cyclophosphamide may increase the cardiotoxic activities of Bexarotene.
Cyclophosphamide Anhydrous
Cyclophosphamide may increase the cardiotoxic activities of Bexarotene.
Cyclosporine
The metabolism of Bexarotene can be decreased when combined with Cyclosporine.
Dabrafenib
The serum concentration of Bexarotene can be decreased when it is combined with Dabrafenib.
Darunavir
The metabolism of Bexarotene can be decreased when combined with Darunavir.
Dasatinib
The serum concentration of Bexarotene can be increased when it is combined with Dasatinib.
Dasatinib Anhydrous
The serum concentration of Bexarotene can be increased when it is combined with Dasatinib.
Deferasirox
The serum concentration of Bexarotene can be decreased when it is combined with Deferasirox.
Delavirdine
The metabolism of Bexarotene can be decreased when combined with Delavirdine.
Demeclocycline
The risk or severity of adverse effects can be increased when Demeclocycline is combined with Bexarotene.
Deslanoside
Deslanoside may decrease the cardiotoxic activities of Bexarotene.
Desogestrel
The serum concentration of Desogestrel can be decreased when it is combined with Bexarotene.
Dienestrol
The serum concentration of Dienestrol can be decreased when it is combined with Bexarotene.
Dienogest
The serum concentration of Dienogest can be decreased when it is combined with Bexarotene.
Diethylstilbestrol
The serum concentration of Diethylstilbestrol can be decreased when it is combined with Bexarotene.
Digitoxin
Digitoxin may decrease the cardiotoxic activities of Bexarotene.
Digoxin
Digoxin may decrease the cardiotoxic activities of Bexarotene.
Dihydroergotamine
The metabolism of Bexarotene can be decreased when combined with Dihydroergotamine.
Diltiazem
The metabolism of Bexarotene can be decreased when combined with Diltiazem.
Dipyrone
The risk or severity of myelosuppression can be increased when Metamizole is combined with Bexarotene.
Docetaxel
The risk or severity of adverse effects can be increased when Docetaxel is combined with Bexarotene.
DOCETAXEL ANHYDROUS
The risk or severity of adverse effects can be increased when Docetaxel is combined with Bexarotene.
Dothiepin
The metabolism of Bexarotene can be decreased when combined with Dosulepin.
Doxycycline
The metabolism of Bexarotene can be decreased when combined with Doxycycline.
Doxycycline Anhydrous
The metabolism of Bexarotene can be decreased when combined with Doxycycline.
Dronedarone
The metabolism of Bexarotene can be decreased when combined with Dronedarone.
Drospirenone
The serum concentration of Drospirenone can be decreased when it is combined with Bexarotene.
Efavirenz
The metabolism of Bexarotene can be decreased when combined with Efavirenz.
Enzalutamide
The serum concentration of Bexarotene can be decreased when it is combined with Enzalutamide.
Erythromycin
The metabolism of Bexarotene can be decreased when combined with Erythromycin.
Estradiol
The serum concentration of Estradiol can be decreased when it is combined with Bexarotene.
Estramustine
The serum concentration of Estramustine can be decreased when it is combined with Bexarotene.
Estrogens, Conjugated (USP)
The serum concentration of Conjugated estrogens can be decreased when it is combined with Bexarotene.
Estrogens, Esterified (USP)
The serum concentration of Estrogens, esterified can be decreased when it is combined with Bexarotene.
Ethinyl Estradiol
The serum concentration of Ethinyl Estradiol can be decreased when it is combined with Bexarotene.
Ethynodiol Diacetate
The serum concentration of Ethynodiol diacetate can be decreased when it is combined with Bexarotene.
Etonogestrel
The serum concentration of Etonogestrel can be decreased when it is combined with Bexarotene.
Etravirine
The metabolism of Bexarotene can be decreased when combined with Etravirine.
Floxuridine
The metabolism of Bexarotene can be decreased when combined with Floxuridine.
Fluconazole
The metabolism of Bexarotene can be decreased when combined with Fluconazole.
Fluorouracil
The metabolism of Bexarotene can be decreased when combined with Fluorouracil.
Fluvastatin
The metabolism of Bexarotene can be decreased when combined with Fluvastatin.
Fluvoxamine
The metabolism of Bexarotene can be decreased when combined with Fluvoxamine.
Fosamprenavir
The metabolism of Bexarotene can be decreased when combined with Fosamprenavir.
Fosaprepitant
The serum concentration of Bexarotene can be increased when it is combined with Fosaprepitant.
Fosphenytoin
The metabolism of Bexarotene can be increased when combined with Fosphenytoin.
Fusidate
The serum concentration of Bexarotene can be increased when it is combined with Fusidic Acid.
Fusidic Acid
The serum concentration of Bexarotene can be increased when it is combined with Fusidic Acid.
Gemfibrozil
The serum concentration of Bexarotene can be increased when it is combined with Gemfibrozil.
Gestodene
The serum concentration of Gestodene can be decreased when it is combined with Bexarotene.
Hypoxis hemerocallidea root extract
The serum concentration of Bexarotene can be decreased when it is combined with St. John's Wort.
Idelalisib
The metabolism of Bexarotene can be decreased when combined with Idelalisib.
Imatinib
The metabolism of Bexarotene can be decreased when combined with Imatinib.
Indinavir
The metabolism of Bexarotene can be decreased when combined with Indinavir.
INDINAVIR ANHYDROUS
The metabolism of Bexarotene can be decreased when combined with Indinavir.
Irbesartan
The metabolism of Bexarotene can be decreased when combined with Irbesartan.
Isavuconazole
The serum concentration of Bexarotene can be increased when it is combined with Isavuconazole.
Isavuconazonium
The metabolism of Bexarotene can be decreased when combined with Isavuconazonium.
Isradipine
The metabolism of Bexarotene can be decreased when combined with Isradipine.
Itraconazole
The metabolism of Bexarotene can be decreased when combined with Itraconazole.
Ivacaftor
The serum concentration of Bexarotene can be increased when it is combined with Ivacaftor.
Ketoconazole
The metabolism of Bexarotene can be decreased when combined with Ketoconazole.
Leflunomide
The metabolism of Bexarotene can be decreased when combined with Leflunomide.
Levonorgestrel
The serum concentration of Levonorgestrel can be decreased when it is combined with Bexarotene.
Lopinavir
The metabolism of Bexarotene can be decreased when combined with Lopinavir.
Losartan
The metabolism of Bexarotene can be decreased when combined with Losartan.
Lovastatin
The metabolism of Bexarotene can be decreased when combined with Lovastatin.
Luliconazole
The serum concentration of Bexarotene can be increased when it is combined with Luliconazole.
Lumacaftor
The serum concentration of Bexarotene can be decreased when it is combined with Lumacaftor.
Lynestrenol
The serum concentration of Lynestrenol can be decreased when it is combined with Bexarotene.
Manidipine
The metabolism of Bexarotene can be decreased when combined with Manidipine.
Medroxyprogesterone Acetate
The serum concentration of Medroxyprogesterone acetate can be decreased when it is combined with Bexarotene.
Mestranol
The serum concentration of Mestranol can be decreased when it is combined with Bexarotene.
Midostaurin
The metabolism of Bexarotene can be decreased when combined with Midostaurin.
Mifepristone
The serum concentration of Bexarotene can be increased when it is combined with Mifepristone.
Minocycline
The risk or severity of adverse effects can be increased when Minocycline is combined with Bexarotene.
Mitotane
The serum concentration of Bexarotene can be decreased when it is combined with Mitotane.
Nefazodone
The metabolism of Bexarotene can be decreased when combined with Nefazodone.
Nelfinavir
The metabolism of Bexarotene can be decreased when combined with Nelfinavir.
Netupitant
The serum concentration of Bexarotene can be increased when it is combined with Netupitant.
Nevirapine
The metabolism of Bexarotene can be increased when combined with Nevirapine.
Nicardipine
The metabolism of Bexarotene can be decreased when combined with Nicardipine.
Nilotinib
The metabolism of Bexarotene can be decreased when combined with Nilotinib.
Norelgestromin
The serum concentration of Norelgestromin can be decreased when it is combined with Bexarotene.
Norgestimate
The serum concentration of Norgestimate can be decreased when it is combined with Bexarotene.
Norgestrel
The serum concentration of Norgestrel can be decreased when it is combined with Bexarotene.
Olaparib
The metabolism of Bexarotene can be decreased when combined with Olaparib.
Omeprazole
The metabolism of Bexarotene can be decreased when combined with Omeprazole.
Osimertinib
The serum concentration of Bexarotene can be increased when it is combined with Osimertinib.
Ouabain
Ouabain may decrease the cardiotoxic activities of Bexarotene.
Ovine Digoxin Immune Fab
Digoxin Immune Fab (Ovine) may decrease the cardiotoxic activities of Bexarotene.
Paclitaxel
The risk or severity of adverse effects can be increased when Paclitaxel is combined with Bexarotene.
Palbociclib
The serum concentration of Bexarotene can be increased when it is combined with Palbociclib.
Pentobarbital
The metabolism of Bexarotene can be increased when combined with Pentobarbital.
Phenobarbital
The metabolism of Bexarotene can be increased when combined with Phenobarbital.
Phenytoin
The metabolism of Bexarotene can be increased when combined with Phenytoin.
Posaconazole
The metabolism of Bexarotene can be decreased when combined with Posaconazole.
Primidone
The metabolism of Bexarotene can be increased when combined with Primidone.
Proscillaridin
Proscillaridin may decrease the cardiotoxic activities of Bexarotene.
Pyrimethamine
The metabolism of Bexarotene can be decreased when combined with Pyrimethamine.
Quinine
The metabolism of Bexarotene can be decreased when combined with Quinine.
Ranolazine
The metabolism of Bexarotene can be decreased when combined with Ranolazine.
Rifabutin
The metabolism of Bexarotene can be increased when combined with Rifabutin.
Rifampin
The metabolism of Bexarotene can be increased when combined with Rifampicin.
Rifapentine
The metabolism of Bexarotene can be increased when combined with Rifapentine.
Rilpivirine
The serum concentration of Rilpivirine can be decreased when it is combined with Bexarotene.
Rucaparib
The metabolism of Bexarotene can be decreased when combined with Rucaparib.
Saquinavir
The metabolism of Bexarotene can be decreased when combined with Saquinavir.
Saquinavir Mesylate
The metabolism of Bexarotene can be decreased when combined with Saquinavir.
Sarilumab
The therapeutic efficacy of Bexarotene can be decreased when used in combination with Sarilumab.
Saxagliptin
The serum concentration of Saxagliptin can be decreased when it is combined with Bexarotene.
Saxagliptin Anhydrous
The serum concentration of Saxagliptin can be decreased when it is combined with Bexarotene.
Secobarbital
The metabolism of Bexarotene can be increased when combined with Secobarbital.
Sildenafil
The metabolism of Bexarotene can be decreased when combined with Sildenafil.
Siltuximab
The serum concentration of Bexarotene can be decreased when it is combined with Siltuximab.
Simeprevir
The serum concentration of Bexarotene can be increased when it is combined with Simeprevir.
Sorafenib
The metabolism of Bexarotene can be decreased when combined with Sorafenib.
ST. JOHN'S WORT EXTRACT
The serum concentration of Bexarotene can be decreased when it is combined with St. John's Wort.
Sulfadiazine
The metabolism of Bexarotene can be decreased when combined with Sulfadiazine.
Sulfamethoxazole
The metabolism of Bexarotene can be decreased when combined with Sulfamethoxazole.
Sulfisoxazole
The metabolism of Bexarotene can be decreased when combined with Sulfisoxazole.
synthetic conjugated estrogens, A
The serum concentration of Synthetic Conjugated Estrogens, A can be decreased when it is combined with Bexarotene.
Tamoxifen
The serum concentration of Tamoxifen can be decreased when it is combined with Bexarotene.
Telaprevir
The metabolism of Bexarotene can be decreased when combined with Telaprevir.
Telithromycin
The metabolism of Bexarotene can be decreased when combined with Telithromycin.
Ticagrelor
The metabolism of Bexarotene can be decreased when combined with Ticagrelor.
Ticlopidine
The metabolism of Bexarotene can be decreased when combined with Ticlopidine.
Tocilizumab
The serum concentration of Bexarotene can be decreased when it is combined with Tocilizumab.
Tolbutamide
The metabolism of Bexarotene can be decreased when combined with Tolbutamide.
Trastuzumab
Trastuzumab may increase the cardiotoxic activities of Bexarotene.
Trimethoprim
The metabolism of Bexarotene can be decreased when combined with Trimethoprim.
Valproate
The metabolism of Bexarotene can be decreased when combined with Valproic Acid.
Valproic Acid
The metabolism of Bexarotene can be decreased when combined with Valproic Acid.
Valsartan
The metabolism of Bexarotene can be decreased when combined with Valsartan.
Vemurafenib
The serum concentration of Bexarotene can be decreased when it is combined with Vemurafenib.
Venlafaxine
The metabolism of Bexarotene can be decreased when combined with Venlafaxine.
Verapamil
The metabolism of Bexarotene can be decreased when combined with Verapamil.
Voriconazole
The metabolism of Bexarotene can be decreased when combined with Voriconazole.
Zafirlukast
The metabolism of Bexarotene can be decreased when combined with Zafirlukast.
Ziprasidone
The metabolism of Bexarotene can be decreased when combined with Ziprasidone.
